BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Status Recruiting

Clinical Trial Summary

This study aims to leverage this unique property of HPV+ OPC to detect possible minimal residual disease represented by persistent viral detection after the completion of definitive treatment. The study will offer adjuvant immune therapy to patients with persistent viral detection and evaluate the clearance of viral load. It will evaluate the rate of viral clearance with immune therapy and establish the link between viral clearance and long-term disease control.

Clinical Trial Description

Objectives: Primary Objective: To assess whether anti-PD1 will lead to the clearance of the virus in the plasma cfDNA in HPV+ OPC patients with persistent cfDNA HPV following definitive therapy Secondary Objectives: - One-year recurrence-free survival (1-yr RFS), - 2-year RFS (2-yr RFS), - Overall survival (2-yr OS), - Safety and tolerability - Compliance - Quality of life (EORTC C30 will be utilized) Correlative/Exploratory Objectives: - Time to viral clearance in the oral rinse and plasma cfDNA with anti-PD1 treatment - The concordance between plasma HPV and oral rinse HPV at diagnosis, post-definitive treatment and during adjuvant treatment - The correlation between tumor mutations and persistence of HPV in oral rinse/cfDNA. - The correlation between recurrence site (loco-regional vs. distant metastasis) and oral rinse vs. plasma HPV detection ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05363709
Study type	Interventional
Source	M.D. Anderson Cancer Center
Contact	Luana Guimaraes de Sousa, MD
Phone	(832) 728-7849
Email	lgsousa@mdanderson.org
Status	Recruiting
Phase	Phase 2
Start date	October 18, 2023
Completion date	February 15, 2028

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03656133` - Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers	N/A
Terminated	`NCT02225496` - Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma	Phase 2
Withdrawn	`NCT01767961` - Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer	N/A
Completed	`NCT01695122` - Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma	Phase 2
Completed	`NCT01435252` - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab	Phase 2
Recruiting	`NCT04708470` - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers	Phase 1/Phase 2
Withdrawn	`NCT00951470` - Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema	N/A
Completed	`NCT01358097` - Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy	N/A
Completed	`NCT00964977` - Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.	Phase 3
Completed	`NCT01342978` - Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time	N/A
Completed	`NCT02280811` - T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers	Phase 2
Active, not recruiting	`NCT03777384` - EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers
Active, not recruiting	`NCT03729518` - TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck	N/A
Recruiting	`NCT06121102` - Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain	N/A
Recruiting	`NCT02984410` - Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma	N/A
Recruiting	`NCT02960724` - uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer	Phase 2
Completed	`NCT02934724` - Impact of HPV Vaccine On The Prevalence Of HPV In Norway
Withdrawn	`NCT00928161` - Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy	N/A
Recruiting	`NCT02012699` - Integrated Cancer Repository for Cancer Research
Terminated	`NCT03555721` - CytID Analysis of Oral Lesions